13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE Filed 2025-01-16 Event 2024-12-03 SEC 0000950170-25-006313 →

Morningside Venture Investments Ltd Kezar Life Sciences, Inc. KZR

Stake: 8.45% Shares: 616,502 CUSIP: 49372L100 Class: Common Stock, par value $0.001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
5 13D/G filings on this issuer
4 other filings besides this one
Filer Track Record
7 filings by this filer
6 other filings in the data moat
Short Interest · settle 2026-04-30
DTC 2.28
158,519 shares short · +4.6% vs prior

Other 13D/G Filings on Kezar Life Sciences, Inc.

FiledFormFilerStakeShares
2026-05-13 SCHEDULE 13D/A TANG CAPITAL MANAGEMENT LLC 0 view →
2025-03-03 SCHEDULE Equal Talent Investments Ltd 8.66% 616,502 view →
2021-02-16 SC Morningside Venture Investments Ltd view →
2020-06-16 SC Morningside Venture Investments Ltd view →

Other Filings by Morningside Venture Investments Ltd

FiledFormIssuerStakeShares
2023-10-04 SC Amylyx Pharmaceuticals, Inc. AMLX view →
2023-04-03 SC Amylyx Pharmaceuticals, Inc. AMLX view →
2023-02-23 SC LumiraDx Ltd view →
2021-11-22 SC Stealth BioTherapeutics Corp view →
2021-02-16 SC Kezar Life Sciences, Inc. KZR view →
2020-06-16 SC Kezar Life Sciences, Inc. KZR view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →